CIM
JAZZ icon

Cambria Investment Management’s Jazz Pharmaceuticals JAZZ Stock Holding History

Cambria Investment Management’s Portfolio JAZZ Stock Details JAZZ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$932K Sell
4,929
-1,131
-19% -$198K 0.05% 246
2025
Q4 		$1.03M Buy
6,060
+171
+3% +$26.2K 0.06% 238
2025
Q3 		$776K Buy
5,889
+391
+7% +$46.9K 0.05% 257
2025
Q2 		$583K Buy
5,498
+3,103
+130% +$337K 0.04% 224
2025
Q1 		$297K Sell
2,395
-1,759
-42% -$229K 0.02% 302
2024
Q4 		$512K Hold
4,154
– – 0.03% 227
2024
Q3 		$463K Buy
4,154
+314
+8% +$34.4K 0.03% 189
2024
Q2 		$410K Sell
3,840
-552
-13% -$60.7K 0.03% 206
2024
Q1 		$529K Sell
4,392
-1,558
-26% -$191K 0.03% 198
2023
Q4 		$732K Hold
5,950
– – 0.05% 149
2023
Q3 		$770K Hold
5,950
– – 0.06% 143
2023
Q2 		$738K Sell
5,950
-782
-12% -$105K 0.06% 145
2023
Q1 		$985K Sell
6,732
-748
-10% -$111K 0.08% 141
2022
Q4 		$1.19M Buy
7,480
+374
+5% +$54.8K 0.1% 161
2022
Q3 		$947K Sell
7,106
-374
-5% -$56.9K 0.1% 143
2022
Q2 		$1.17M Hold
7,480
– – 0.15% 135
2022
Q1 		$1.16M Sell
7,480
-1,317
-15% -$191K 0.15% 137
2021
Q4 		$1.12M Sell
8,797
-657
-7% -$86.3K 0.19% 139
2021
Q3 		$1.23M Buy
9,454
+438
+5% +$66.2K 0.23% 137
2021
Q2 		$1.6M Buy
+9,016
New +$1.56M 0.28% 134

Other funds holding JAZZ

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
LSV Asset Management
LSV Asset Management Chicago, Illinois $46.4B AUM 27.74% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return

Cambria Investment Management's JAZZ Position: Q1 2026 in Review

Cambria Investment Management reduced its Jazz Pharmaceuticals (JAZZ) stake by 19% in Q1 2026, selling an estimated $198K and leaving 4,929 shares worth $932K. The position accounts for 0.05% of the portfolio, ranked #246.

Cambria Investment Management first reported a position in JAZZ in Q2 2021 and has held it in 20 quarters since. The position peaked at $1.6M in Q2 2021. 571 funds tracked by Wall St. Rank hold JAZZ as of Q1 2026.

  • Cambria Investment Management held 4,929 shares of Jazz Pharmaceuticals worth $932K as of Q1 2026.
  • Cambria Investment Management sold 1,131 Jazz Pharmaceuticals shares in Q1 2026, an estimated $198K.
  • Jazz Pharmaceuticals made up 0.05% of Cambria Investment Management's portfolio in Q1 2026, its #246 holding.
  • Cambria Investment Management first reported a position in Jazz Pharmaceuticals in Q2 2021 and has held it in 20 quarters since.
  • Cambria Investment Management's Jazz Pharmaceuticals position peaked at $1.6M in Q2 2021.
  • 571 funds tracked by Wall St. Rank held Jazz Pharmaceuticals as of Q1 2026.

Based on Cambria Investment Management's 13F filing for Q1 2026, filed 15 May 2026.